CVS Caremark overcharges seniors and disabled, settles FTC charge

January 13, 2012

CVS Caremark Corporation will pay $5 million to settle Federal Trade Commission charges that it misrepresented the prices of certain Medicare Part D prescription drugs – including drugs used to treat breast cancer symptoms and epilepsy – at CVS and Walgreens pharmacies.

The allegedly deceptive claims caused many seniors and disabled consumers to pay significantly more for their drugs than they expected and pushed them into the “donut hole” – a term referring to the coverage gap where none of their drug costs are reimbursed – sooner than they anticipated or planned. The settlement will bar deceptive claims related to Medicare Part D drug prices and require CVS Caremark to pay $5 million to reimburse affected Medicare Part D consumers for the price discrepancy.

“This settlement puts money back in the pockets of older Americans who struggle to pay for their medications,” said FTC Chairman Jon Leibowitz. “With the cost of health care on the rise, the FTC is especially focused on protecting consumers from any deceptive claims that would cause them to pay more than they should.”

You Might Also Like

  • Dixie Thompson January 13, 2012 at 1:58 pm

    As long as there is profit motive in healthcare, abuses will continue. Why are we the only country out of the developed, rich nations without some sort of national healthcare service? And scraping the bottom of rankings for services and outcomes? With 45,000 Americans a year dying from lack of access?